CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.
After years of research, CHOC implemented advanced protocols that could produce a distinct reduction in chronic lung disease in infants.
The ACTS program at the Hyundai Cancer Institute at CHOC receives recognition for their work to provide long-term care to cancer survivors.
CHOC takes a multidisciplinary approach to detect AMV and treat it with life-saving neurointerventional surgery.
CHOC is at the forefront of bringing precise, advanced 3D brain imaging to neurologists and their patients.